|
|
|
|
| Symbol(s): |
SGEN |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Seattle Genetics has a current Overall Rating of D (Negative). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Seattle Genetics has a current Overall Rating of D (Negative). Power Rating (35) is low; appreciation potential (3) is negative. Relative to the S&P 500 Composite, Seattle Genetics Inc has both Growth and Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. SGEN is of low investment quality. Seattle Genetics' current technical position is mixed. Seattle Genetics' Power Rating is 35. However, the recent trend in SGEN's earnings estimates has been...
| | |
|
|
